Neal Walker
2021
In 2021, Neal Walker earned a total compensation of $6.9M as President and Chief Executive Officer at Aclaris Therapeutics, a 326% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $387,486 |
|---|---|
| Option Awards | $4,130,564 |
| Salary | $566,500 |
| Stock Awards | $1,758,786 |
| Other | $11,600 |
| Total | $6,854,936 |
Walker received $4.1M in option awards, accounting for 60% of the total pay in 2021.
Walker also received $387.5K in non-equity incentive plan, $566.5K in salary, $1.8M in stock awards and $11.6K in other compensation.
Rankings
In 2021, Neal Walker's compensation ranked 1,807th out of 12,415 executives tracked by ExecPay. In other words, Walker earned more than 85.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,807 out of 12,415 | 85th |
Division Manufacturing | 672 out of 5,508 | 88th |
Major group Chemicals And Allied Products | 253 out of 2,378 | 89th |
Industry group Drugs | 214 out of 2,099 | 90th |
Industry Pharmaceutical Preparations | 146 out of 1,549 | 91st |
Source: SEC filing on April 21, 2022.
Walker's colleagues
We found four more compensation records of executives who worked with Neal Walker at Aclaris Therapeutics in 2021.